Douglas S. Robinson
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Cyclodextrin-siderophore conjugates as a Trojan horse strategy for bacterial targeting.
Journal: Journal of inorganic biochemistry
Published: November 28, 2025
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma.
Journal: ERJ open research
Published: October 21, 2024
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study.
Journal: American journal of respiratory and critical care medicine
Published: April 18, 2024
Breathing pattern disorder in chronic rhinosinusitis with severe asthma: nasal obstruction and polyps do not increase prevalence.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: September 05, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex.
Journal: The journal of allergy and clinical immunology. In practice
Published: June 15, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.
Journal: American journal of respiratory and critical care medicine
Published: May 13, 2022
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
Journal: The European respiratory journal
Published: March 15, 2021
Chronic rhinosinusitis with and without nasal polyps and asthma: Omalizumab improves residual anxiety but not depression.
Journal: Clinical and translational allergy
Published: December 31, 2020
Chronic Rhinosinusitis With Nasal Polyps In Patients With Aspirin Sensitivity-Mycophenolate Mofetil as an Effective Steroid-Sparing Agent.
Journal: JAMA otolaryngology-- head & neck surgery
Published: October 08, 2020
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Journal: The Lancet. Respiratory medicine
Published: August 04, 2020
Supramolecular architecture of a multi-component biomimetic lipid barrier formulation.
Journal: Journal of colloid and interface science
Published: July 19, 2020
Last Updated: 09/26/2026